Concepts (159)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Analgesics, Opioid | 11 | 2022 | 498 | 4.210 |
Why?
|
| Nerve Block | 7 | 2022 | 55 | 4.150 |
Why?
|
| Pain, Postoperative | 13 | 2022 | 214 | 3.560 |
Why?
|
| Arthroplasty, Replacement, Hip | 6 | 2022 | 130 | 2.750 |
Why?
|
| Analgesia | 4 | 2022 | 58 | 2.570 |
Why?
|
| Analgesia, Epidural | 5 | 2018 | 40 | 2.310 |
Why?
|
| Autonomic Nerve Block | 3 | 2023 | 15 | 1.990 |
Why?
|
| Anesthetics, Local | 7 | 2022 | 83 | 1.610 |
Why?
|
| Acetaminophen | 3 | 2022 | 111 | 1.470 |
Why?
|
| Analgesics, Non-Narcotic | 2 | 2022 | 45 | 1.420 |
Why?
|
| Arthroscopy | 4 | 2022 | 95 | 1.320 |
Why?
|
| Anesthesia, Conduction | 3 | 2022 | 14 | 1.310 |
Why?
|
| Dexamethasone | 3 | 2018 | 150 | 1.230 |
Why?
|
| Hypothermia | 2 | 2018 | 37 | 1.190 |
Why?
|
| Brachial Plexus Block | 2 | 2018 | 5 | 1.150 |
Why?
|
| Arthroplasty, Replacement, Knee | 3 | 2018 | 146 | 1.090 |
Why?
|
| Analgesia, Obstetrical | 2 | 2018 | 15 | 1.080 |
Why?
|
| Lumbosacral Plexus | 4 | 2022 | 15 | 0.960 |
Why?
|
| Anesthesia, General | 2 | 2015 | 86 | 0.890 |
Why?
|
| Stellate Ganglion | 1 | 2023 | 9 | 0.870 |
Why?
|
| Pain Measurement | 6 | 2022 | 328 | 0.850 |
Why?
|
| Acute Pain | 1 | 2022 | 35 | 0.790 |
Why?
|
| Postoperative Period | 4 | 2022 | 238 | 0.770 |
Why?
|
| Anesthesia, Spinal | 2 | 2019 | 16 | 0.760 |
Why?
|
| Hyperalgesia | 1 | 2021 | 18 | 0.760 |
Why?
|
| Delirium | 1 | 2021 | 45 | 0.750 |
Why?
|
| Humans | 34 | 2023 | 68618 | 0.690 |
Why?
|
| Dementia | 1 | 2021 | 158 | 0.690 |
Why?
|
| Breakthrough Pain | 1 | 2019 | 3 | 0.690 |
Why?
|
| Cesarean Section | 1 | 2019 | 101 | 0.650 |
Why?
|
| Spinal Cord Ischemia | 1 | 2018 | 21 | 0.630 |
Why?
|
| Rib Fractures | 1 | 2018 | 37 | 0.610 |
Why?
|
| Hypotension | 1 | 2018 | 74 | 0.610 |
Why?
|
| Labor, Obstetric | 1 | 2018 | 23 | 0.610 |
Why?
|
| Needles | 1 | 2018 | 34 | 0.610 |
Why?
|
| Bupivacaine | 1 | 2018 | 27 | 0.600 |
Why?
|
| Paresis | 1 | 2018 | 78 | 0.590 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2018 | 234 | 0.580 |
Why?
|
| Hemiarthroplasty | 1 | 2015 | 7 | 0.530 |
Why?
|
| Femoral Nerve | 1 | 2015 | 8 | 0.510 |
Why?
|
| Mobility Limitation | 1 | 2015 | 27 | 0.500 |
Why?
|
| Anesthesiology | 1 | 2015 | 63 | 0.500 |
Why?
|
| Muscle Strength | 1 | 2015 | 62 | 0.490 |
Why?
|
| Aortic Valve Stenosis | 1 | 2015 | 177 | 0.460 |
Why?
|
| Airway Management | 1 | 2013 | 20 | 0.450 |
Why?
|
| Amides | 2 | 2013 | 86 | 0.450 |
Why?
|
| Nervous System Diseases | 1 | 2014 | 142 | 0.440 |
Why?
|
| Intubation, Intratracheal | 1 | 2013 | 99 | 0.430 |
Why?
|
| Pregnancy | 4 | 2019 | 2334 | 0.410 |
Why?
|
| Intraoperative Awareness | 1 | 2011 | 2 | 0.400 |
Why?
|
| Consciousness Monitors | 1 | 2011 | 2 | 0.400 |
Why?
|
| Anesthetics, Inhalation | 1 | 2011 | 21 | 0.400 |
Why?
|
| Pulmonary Alveoli | 1 | 2011 | 62 | 0.390 |
Why?
|
| Monitoring, Intraoperative | 1 | 2011 | 53 | 0.390 |
Why?
|
| Retrospective Studies | 7 | 2023 | 7277 | 0.390 |
Why?
|
| Female | 16 | 2022 | 38074 | 0.390 |
Why?
|
| Analgesics | 3 | 2022 | 118 | 0.370 |
Why?
|
| Administration, Intravenous | 2 | 2019 | 89 | 0.340 |
Why?
|
| Aged | 9 | 2022 | 14862 | 0.330 |
Why?
|
| Adult | 8 | 2022 | 21403 | 0.310 |
Why?
|
| Cohort Studies | 4 | 2018 | 2358 | 0.300 |
Why?
|
| Male | 12 | 2018 | 37321 | 0.290 |
Why?
|
| Pain Management | 2 | 2019 | 186 | 0.270 |
Why?
|
| Middle Aged | 8 | 2018 | 21147 | 0.270 |
Why?
|
| Retinal Vessels | 2 | 2003 | 74 | 0.260 |
Why?
|
| Mastectomy | 2 | 2022 | 57 | 0.250 |
Why?
|
| Endothelium, Vascular | 2 | 2003 | 371 | 0.230 |
Why?
|
| Prospective Studies | 3 | 2018 | 3705 | 0.230 |
Why?
|
| Incidence | 2 | 2018 | 1603 | 0.220 |
Why?
|
| Integrin alpha5beta1 | 1 | 2003 | 9 | 0.220 |
Why?
|
| Critical Pathways | 1 | 2023 | 33 | 0.220 |
Why?
|
| Fibronectins | 1 | 2003 | 130 | 0.210 |
Why?
|
| Thoracic Nerves | 1 | 2022 | 2 | 0.210 |
Why?
|
| Breast Neoplasms | 2 | 2022 | 1536 | 0.210 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 250 | 0.200 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2003 | 223 | 0.200 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2023 | 239 | 0.190 |
Why?
|
| Elective Surgical Procedures | 2 | 2018 | 95 | 0.180 |
Why?
|
| Intraoperative Complications | 2 | 2018 | 129 | 0.180 |
Why?
|
| Time Factors | 2 | 2018 | 4655 | 0.170 |
Why?
|
| Ketorolac | 1 | 2019 | 11 | 0.170 |
Why?
|
| Administration, Oral | 1 | 2019 | 411 | 0.160 |
Why?
|
| Injections, Spinal | 1 | 2018 | 18 | 0.150 |
Why?
|
| Heart | 1 | 2023 | 850 | 0.150 |
Why?
|
| Body Temperature | 1 | 2018 | 116 | 0.150 |
Why?
|
| Accidents, Traffic | 1 | 2018 | 109 | 0.150 |
Why?
|
| Bias | 1 | 2018 | 148 | 0.150 |
Why?
|
| Pain | 1 | 2021 | 472 | 0.150 |
Why?
|
| Early Ambulation | 1 | 2017 | 8 | 0.150 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 240 | 0.140 |
Why?
|
| Tranexamic Acid | 1 | 2017 | 37 | 0.140 |
Why?
|
| Antifibrinolytic Agents | 1 | 2017 | 52 | 0.140 |
Why?
|
| Blood Loss, Surgical | 1 | 2017 | 79 | 0.140 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 649 | 0.140 |
Why?
|
| Partial Thromboplastin Time | 1 | 2016 | 57 | 0.140 |
Why?
|
| Morphine | 1 | 2016 | 76 | 0.130 |
Why?
|
| Femoral Neck Fractures | 1 | 2015 | 7 | 0.130 |
Why?
|
| Osteoarthritis, Hip | 1 | 2015 | 12 | 0.130 |
Why?
|
| Hip | 1 | 2015 | 19 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2018 | 1745 | 0.130 |
Why?
|
| Fatal Outcome | 1 | 2015 | 164 | 0.130 |
Why?
|
| Catheterization | 1 | 2016 | 209 | 0.130 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 4848 | 0.130 |
Why?
|
| Heparin | 1 | 2016 | 205 | 0.130 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 951 | 0.120 |
Why?
|
| Ultrasonography, Interventional | 1 | 2014 | 119 | 0.110 |
Why?
|
| Patient Care Team | 1 | 2015 | 311 | 0.110 |
Why?
|
| Anticoagulants | 1 | 2016 | 356 | 0.110 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2014 | 178 | 0.110 |
Why?
|
| Regression Analysis | 1 | 2014 | 737 | 0.100 |
Why?
|
| Cell Division | 2 | 2003 | 541 | 0.100 |
Why?
|
| Double-Blind Method | 1 | 2013 | 1738 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 2223 | 0.080 |
Why?
|
| Stents | 1 | 2014 | 657 | 0.080 |
Why?
|
| Myocardial Infarction | 1 | 2014 | 807 | 0.080 |
Why?
|
| Young Adult | 1 | 2019 | 5717 | 0.080 |
Why?
|
| Postoperative Complications | 1 | 2015 | 1615 | 0.080 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 2 | 2003 | 95 | 0.070 |
Why?
|
| Blood Transfusion | 2 | 2017 | 205 | 0.060 |
Why?
|
| Antibodies, Blocking | 1 | 2003 | 17 | 0.060 |
Why?
|
| Child | 1 | 2014 | 6405 | 0.050 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2003 | 46 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2022 | 62 | 0.050 |
Why?
|
| Cell Adhesion | 1 | 2003 | 324 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2003 | 489 | 0.050 |
Why?
|
| Documentation | 1 | 2022 | 83 | 0.050 |
Why?
|
| Adolescent | 1 | 2014 | 8912 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 710 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2003 | 791 | 0.050 |
Why?
|
| Breast | 1 | 2022 | 137 | 0.050 |
Why?
|
| Consensus | 1 | 2022 | 211 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2003 | 483 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 659 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2003 | 2673 | 0.040 |
Why?
|
| Reference Standards | 1 | 2017 | 115 | 0.040 |
Why?
|
| Postoperative Hemorrhage | 1 | 2017 | 69 | 0.030 |
Why?
|
| Cost Savings | 1 | 2017 | 110 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2016 | 87 | 0.030 |
Why?
|
| Apoptosis | 1 | 2003 | 1641 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2017 | 504 | 0.030 |
Why?
|
| Venous Thromboembolism | 1 | 2016 | 117 | 0.030 |
Why?
|
| Epidural Space | 1 | 2014 | 15 | 0.030 |
Why?
|
| Liver Diseases | 1 | 2016 | 193 | 0.030 |
Why?
|
| Catheters | 1 | 2014 | 39 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2016 | 295 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2003 | 2689 | 0.030 |
Why?
|
| Device Removal | 1 | 2014 | 100 | 0.030 |
Why?
|
| Cognition | 1 | 2017 | 513 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2017 | 413 | 0.030 |
Why?
|
| Age Factors | 1 | 2016 | 1864 | 0.020 |
Why?
|
| Annexin A5 | 1 | 2003 | 16 | 0.010 |
Why?
|
| Tetrazolium Salts | 1 | 2003 | 36 | 0.010 |
Why?
|
| Receptors, Somatostatin | 1 | 2003 | 7 | 0.010 |
Why?
|
| Nitrobenzenes | 1 | 2003 | 13 | 0.010 |
Why?
|
| Thiazoles | 1 | 2003 | 95 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2003 | 189 | 0.010 |
Why?
|
| Indoles | 1 | 2003 | 146 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 507 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 742 | 0.010 |
Why?
|